Zhou Sha1, Kejie Chang1, Jiaoping Mi2, Zibin Liang1, Liyang Hu1, Fengjiao Long1, Haiyan Shi1, Zhong Lin1, Xiaojin Wang3, Xiaofeng Pei4. 1. Department of Thoracic Oncology, Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. 2. Department of Otorhinolaryngology of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. 3. Department of Cardiothoracic Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. wxjhny@163.com. 4. Department of Thoracic Oncology, Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. peixf3@mail.sysu.edu.cn.
Abstract
BACKGROUND: The coronavirus disease (COVID-19) poses an unprecedented challenge to health and epidemic prevention system, especially the healthcare of patients with cancer. We sought to study the impact of COVID-19 on lung cancer patients in our center. METHODS: We initiated a retrospectively study to analyze the impact of COVID-19 on lung cancer patients in our center, who were accepted for routine anticancer treatment before the epidemic and planned to return to hospital in January and February of 2020. RESULTS: A total of 161 cases of lung cancer were included in the final analysis. As of April 15, 95 patients had delayed their return visit, and 47 cases were finally designated as having delayed admission during the epidemic and having to discontinue or delay their regular anticancer treatments. Of these 47 delayed patients, 33 were evaluated for tumor status using a computed tomography scan, 6 of these 33 cases (18.18%) were diagnosed as progressive disease (PD), and 5 cases did not return for visit. CONCLUSIONS: This is the first study investigating impact of COVID-19 on non-COVID-19 lung cancer patients during the pandemic. The study demonstrates the significant impact of the COVID-19 crisis on oncological care, indicating the need for appropriate change of treatment decisions and continued follow-up and psycho-oncological support during this pandemic.
BACKGROUND: The coronavirus disease (COVID-19) poses an unprecedented challenge to health and epidemic prevention system, especially the healthcare of patients with cancer. We sought to study the impact of COVID-19 on lung cancerpatients in our center. METHODS: We initiated a retrospectively study to analyze the impact of COVID-19 on lung cancerpatients in our center, who were accepted for routine anticancer treatment before the epidemic and planned to return to hospital in January and February of 2020. RESULTS: A total of 161 cases of lung cancer were included in the final analysis. As of April 15, 95 patients had delayed their return visit, and 47 cases were finally designated as having delayed admission during the epidemic and having to discontinue or delay their regular anticancer treatments. Of these 47 delayed patients, 33 were evaluated for tumor status using a computed tomography scan, 6 of these 33 cases (18.18%) were diagnosed as progressive disease (PD), and 5 cases did not return for visit. CONCLUSIONS: This is the first study investigating impact of COVID-19 on non-COVID-19lung cancerpatients during the pandemic. The study demonstrates the significant impact of the COVID-19 crisis on oncological care, indicating the need for appropriate change of treatment decisions and continued follow-up and psycho-oncological support during this pandemic.
Entities:
Keywords:
COVID-19; anti-cancer treatment; lung cancer
Authors: Thomas Round; Veline L'Esperance; Joanne Bayly; Kate Brain; Lorraine Dallas; John G Edwards; Thomas Haswell; Crispin Hiley; Natasha Lovell; Julia McAdam; Grace McCutchan; Arjun Nair; Thomas Newsom-Davis; Elizabeth K Sage; Neal Navani Journal: Br J Cancer Date: 2021-05-10 Impact factor: 7.640
Authors: Eusebi Chiner-Vives; Rosa Cordovilla-Pérez; David de la Rosa-Carrillo; Marta García-Clemente; José Luis Izquierdo-Alonso; Remedios Otero-Candelera; Luis Pérez-de Llano; Jacobo Sellares-Torres; José Ignacio de Granda-Orive Journal: Arch Bronconeumol Date: 2022-04-15 Impact factor: 6.333
Authors: Angelo Minucci; Giovanni Scambia; Maria De Bonis; Elisa De Paolis; Concetta Santonocito; Anna Fagotti; Ettore Capoluongo; Paola Concolino; Andrea Urbani Journal: Mol Biol Rep Date: 2020-12-12 Impact factor: 2.316
Authors: Egidio Imbalzano; Luana Orlando; Angela Sciacqua; Giuseppe Nato; Francesco Dentali; Veronica Nassisi; Vincenzo Russo; Giuseppe Camporese; Gianluca Bagnato; Arrigo F G Cicero; Giuseppe Dattilo; Marco Vatrano; Antonio Giovanni Versace; Giovanni Squadrito; Pierpaolo Di Micco Journal: J Clin Med Date: 2021-12-31 Impact factor: 4.241
Authors: Hanqing Liu; Ling Zhan; Liantao Guo; Xizi Yu; Lingrui Li; Hongfang Feng; Dan Yang; Zhiliang Xu; Yi Tu; Chuang Chen; Shengrong Sun Journal: Int J Gen Med Date: 2021-10-27